Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Feb
15
2023
You Can Go Your Own Way: Washington’s Cannabis License Residency Requirement Upheld, Breaking the Chain of Contrary Decisions Bradley Arant Boult Cummings LLP
Feb
14
2023
FDA Issues Warning Letter to RightEye, LLC For Misbranding and Adulteration Sheppard, Mullin, Richter & Hampton LLP
Feb
14
2023
CVM Holds Virtual Meeting on AAFCO Feed Ingredient Definition Process Keller and Heckman LLP
Feb
13
2023
REGULATORY YEARLY WRAP 2022: Medical Devices in India Nishith Desai Associates
Feb
13
2023
Old North State Report – Feb. 13, 2023 Nelson Mullins
Feb
13
2023
Gerber Seeks Dismissal of Putative Class Action Over Allegedly Misleading Protein Content Claims on Baby Food Containing Added Sugar Keller and Heckman LLP
Feb
13
2023
Senate Judiciary Committee Pushes Pharma Patents and Pricing Bills Forward Foley & Lardner LLP
Feb
13
2023
Alabama Medical Cannabis: Deficiency Day Bradley Arant Boult Cummings LLP
Feb
13
2023
FDA’s Digital Health High Notes from 2022 Mintz
Feb
13
2023
Missouri Joins States Legalizing Recreational Marijuana – Cutting Through the Haze on Missouri Amendment 3 Polsinelli PC
Feb
10
2023
Interstate Cannabis Commerce on the Horizon Thanks to California Stark & Stark
Feb
10
2023
DEA Supports Elimination of X-Waiver Requirement for Prescribing of Buprenorphine McDermott Will & Emery
Feb
9
2023
Podcast: Unpacking FDA’s Final Clinical Decision Support Guidance – Diagnosing Health Care [VIDEO] Epstein Becker & Green, P.C.
Feb
9
2023
USDA Seeks Public Comment on Proposal to Strengthen Animal Disease Traceability Regulations Keller and Heckman LLP
Feb
9
2023
Minnesota Legislature Takes Up Noncompetition, Paid Family Leave, Cannabis Legalization, and Privacy Bills in 2023 Session Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Feb
8
2023
Cultured Meat 101: The Science and Premarket Process Womble Bond Dickinson (US) LLP
Feb
7
2023
The EU’s Tobacco Products Directive: Revisiting the Requirements and Updates on Heated Tobacco Products Keller and Heckman LLP
Feb
7
2023
Will the Tennessee Legislature Continue to Leave Cannabis to Outlaw Country Music in 2023? Bradley Arant Boult Cummings LLP
Feb
7
2023
USDA Announces Proposed Changes to School Meal Program Keller and Heckman LLP
Feb
6
2023
Kerry Inc. Pleads Guilty to Unsanitary Manufacturing Charges for Honey Smacks Cereal Linked to 2018 Salmonellosis Outbreak Keller and Heckman LLP
Feb
5
2023
Kerry Inc. Pleads Guilty and Agrees to Pay $19.228 Million in Connection with Insanitary Plant Conditions Linked to 2018 Salmonella Poisoning Outbreak The U.S. Department of Justice
Feb
3
2023
Bankruptcy Court Finds Cannabis Employee Not Entitled to Chapter 13 Protection Mintz
Feb
3
2023
FDA Announces Qualified Health Claim for Cocoa Flavanols in High Flavanol Cocoa Powder and Reduced Risk of Cardiovascular Disease Keller and Heckman LLP
Feb
3
2023
Revamping of Cosmetics Regulation and Safety Squire Patton Boggs (US) LLP
Feb
2
2023
Food and Chemicals Unpacked: Extended Producer Responsibility: EPR You Ready? [PODCAST] Keller and Heckman LLP
Feb
2
2023
340B Covered Entities May See Access Changes to Contrast Media, Radiopharmaceuticals and Other Products McDermott Will & Emery
Feb
2
2023
EU Tightens Checks on Vanilla Extract from US Keller and Heckman LLP
Feb
1
2023
Not so FAST – AB 257 on Hold Pending Voter Referendum in 2024 Jackson Lewis P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins